Celesio, a German service provider for pharmaceutical and healthcare markets, has acquired 60% of Oncoprod Group, a Brazilian wholesaler for specialty pharmaceuticals.
Subscribe to our email newsletter
The move in this direction has been made on the back of growing potential in the Brazilian pharma market.
Celesio CEO Markus Pinger said Brazil’s healthcare market grows above average, especially in the area of Specialty Pharmaceuticals and the acquisition is an optimal addition to Panpharma, their Brazilian wholesaler.
"With both companies we are focusing on our core competencies in pharmaceutical wholesale and distribution of specialty pharmaceuticals," Pinger added.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.